Takeda To Rely On M&A, Emerging Market Expansion To Offset Patent Losses

Japan's largest drug company Takeda hopes to minimize the impact of looming patent expirations in the U.S. by relying on mergers and acquisitions to increase its pipeline and extend its territory coverage, especially in emerging countries

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip